Produktname:5-bromopyrimidine

IUPAC Name:5-bromopyrimidine

CAS:4595-59-9
Molekulare Formel:C4H3BrN2
Reinheit:98%
Katalognummer:CM108025
Molekulargewicht:158.99

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM108025-1000g in stock Ǻňș

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:4595-59-9
Molekulare Formel:C4H3BrN2
Schmelzpunkt:-
SMILES-Code:BrC1=CN=CN=C1
Dichte:
Katalognummer:CM108025
Molekulargewicht:158.99
Siedepunkt:
Mdl-Nr.:MFCD00006117
Lagerung:

Category Infos

Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

Column Infos

Revumenib
Syndax announced pivotal AUGMENT-101 trial of Revumenib in relapsed/refractory KMT2Ar acute leukemia met primary endpoint and stopped early for efficacy following protocol-defined interim analysis. Revumenib is a potent, selective, small molecule inhibitor of the menin-KMT2A binding interaction that is being developed for the treatment of KMT2A-rearranged, also known as mixed lineage leukemia rearranged or MLLr, acute leukemias including ALL and AML, and NPM1-mutant AML.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.